Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2023-12-28 00:00:00 ET · period of report 2023-12-28 · accession 0001415889-23-016992 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-28 | 2023-12-28 | PTCT | Klein Matthew B. | CEO, Dir | A - Grant | $0.00 | +75.0K | 178.0K | +73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-28 | A | A | 75,000 | $0.00 | 177,961 | D | — | — | (F1) Restricted stock unit granted on December 28, 2023 that vests in four equal installments over four years, commencing on December 29, 2023. (F2) Includes 316 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023. |